Como a psicoterapia é diferente quando o terapeuta também é um sobrevivente? Que lições vitais os terapeutas devem aprender com as pessoas que experimentaram...
Dr Irving Kirsch is Associate Director of the Program in Placebo Studies and lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center. He joins us this week to discuss his research into the placebo effect and what it tells us about the efficacy of antidepressant drugs.
An interview with Dr. David Healy, internationally respected psychiatrist, psychopharmacologist, scientist, and author, discussing Post SSRI Sexual Dysfunction (PSSD) and his innovative approach to finding a cure.
An interview with psychiatrist, academic and author Dr Joanna Moncrieff, one of the founding members of the Critical Psychiatry Network. We talk about the recent meta-analysis of the efficacy and tolerability of 21 antidepressant drugs, widely reported in the UK news media on February 22nd.
Psychiatrist Jim van Os is Chairman of the Department of Psychiatry and Psychology at Maastricht University Medical Centre, Maastricht, The Netherlands. He challenges current diagnostic conceptions of schizophrenia and other mental disorders, and offers a vision for creating a new paradigm of mental health care.
An interview with journalist and author Johann Hari about his latest book: Lost Connections: Uncovering the Real causes of Depression and the Unexpected Solutions, in which he learned that almost everything we have been told about depression and anxiety is wrong.
Kermit Cole tells of his experiences of supporting those in extreme states and his thoughts on Open Dialogue and dialogical approaches in general.
This week on the Mad in America podcast we interview Olga Runciman. Olga is an international trainer and speaker, writer, campaigner, and artist. In this interview, we discuss Olga’s professional and personal experiences of the psychiatric system and how she now helps and supports healing and recovery in others.
On this episode of the MIA Radio podcast, we present part one of an interview with Dr. Peter Breggin about his career, his views on psychiatry and recent developments with the Michelle Carter trial in which he testified as an expert medical witness.
Dr Beggin tells us about recent developments with the Michelle Carter trial, and we discuss alternatives to psychiatric drugs and the value of the therapeutic relationship.
12Página 1 de 2